Cisatracurium

CAS 96946-41-7 2 current recordsSmall Molecule

Who holds supplier records for Cisatracurium? 2 organisations hold a current record for Cisatracurium: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Israel (1); not recorded for 1.

Most records are filed under another form of this substance: Cisatracurium Besylate (7 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cisatracurium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cisatracurium

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cisatracurium. Country is the organisation's recorded country, not necessarily the manufacturing site.

Israel1Country not recorded for 1
  • CF PHARMA LTD
    Active DMF 24902 · latest filing Aug 2012
  • WAVELENGTH ENTERPRISES LTD
    Active DMF 39123 · latest filing Jan 2024
    Israel Company GMP cert on record
Need Cisatracurium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cisatracurium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201248).

Chemical identity

IUPAC name
5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
Canonical SMILES
C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C
InChIKey
YXSLJKQTIDHPOT-LJCJQEJUSA-N
Synonyms
Cisatracurium, Cisatracurium cation, Cisatracurium ion, Nimbex, CHEBI:140621, RefChem:56878, CISATRACURIUM [VANDF], CISATRACURIUM [WHO-DD], (1R-cis,1'R-cis)-atracurium, (1R,2R,1'R,2'R)-atracurium, DB00565, DB13450

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cisatracurium?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Cisatracurium: CF PHARMA LTD and WAVELENGTH ENTERPRISES LTD (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cisatracurium Drug Master Files are active?

CF PHARMA LTD (DMF 24902) and WAVELENGTH ENTERPRISES LTD (DMF 39123). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Cisatracurium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cisatracurium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.